For the molecular subtype, more triple-negative breast cancers were found in patients with GPVs in BRCA1 and other CPGs than the non-carriers (68.6% and 26.8% vs. 14.9%, p=4.7×10-42 and 0.01; Table 1). Here, BRCA1 is linked to triple-negative breast carcinoma.